The effect of thymosine 1 alpha and Lamivudine combination therapy in chronic hepatitis B patients.
Dikici
Bunyamin
B
Bosnak
Mehmet
M
Haspolat
Kenan
K
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000627:therapeutic use*; D002648:Child; D004359:Drug Therapy, Combination; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage* / Q000627:therapeutic use*; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use*; D000077596:Thymalfasin; D013947:Thymosin / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D013947:Thymosin; D000077596:Thymalfasin